We studied the efficacy of a range of doses of dexamethasone for prevention of postoperative nausea and vomiting following strabismus repair in children in a hospital-based, prospective, double-blinded, randomized, placebocontrolled 
Nausea and vomiting during the postoperative period have been described as one of the most troublesome minor complications following anaesthesia 1 despite the availability of a range of antiemetic drugs. The incidence of postoperative nausea and vomiting (PONV) varies widely and is influenced by the age and gender of patients, type and duration of anaesthesia and nature of surgery 2, 3 . PONV has a high incidence among children who undergo strabismus repair surgery 2 . Several pharmacological agents have been evaluated for the prevention of PONV with varying degree of success. In recent years, dexamethasone has been reported to be an effective anti-emetic following surgical procedures including tonsillectomy and strabismus repair [4] [5] [6] . In adult females, the minimum effective dose has been variously reported to range from 2.5 mg to 8.0 mg [7] [8] [9] [10] . In the paediatric age group, there has been no report determining the minimum effective dose based on weight. Quantitative systematic reviews of the use of dexamethasone in children have found that 0.15 to 1.0 mg/kg was effective in reducing postoperative vomiting 11, 12 . This study was undertaken to assess the efficacy and safety of lower doses of dexamethasone for preventing post-strabismus repair nausea and vomiting in children.
MATERIAL AND METHODS
The study was initiated after obtaining the approval of the Institutional Ethics Committee and children were enrolled with prior written informed consent of their parent or guardian. Male or female children, aged 2 to 15 years, rated as ASA 1 or 2 and scheduled for elective strabismus repair were eligible for inclusion in the study. Those with a history of motion sickness, a previous episode of PONV and those who had received steroids or medication with known anti-emetic activity during the 24 hours preceding surgery were excluded. In order to detect a 50% decrease in the incidence of vomiting from a baseline incidence of 80% 13, 14 , with an alpha error of 0.05 and power of 95%, 42 children needed to be recruited into each intervention arm.
During the preanaesthetic visit, children six years or older were taught the use of the visual analogue scale (VAS 0-10) to assess nausea and their baseline nausea score was recorded. All children were required to fast from solids for eight hours and from clear liquids for three hours prior to surgery. No premedication was used.
Prior to anaesthesia, children were randomized, using a computer generated random number table and the sealed cover technique, to one of five intervention groups: Group 1 (dexamethasone 50 µg/kg), Group 2 (dexamethasone 100 µg/kg), group 3 (dexamethasone 200 µg/kg), group 4 (dexamethasone 250 µg/kg) and group 5 (normal saline). The study drug was administered intravenously as a clear liquid prepared to a volume of 5 ml, by personnel blinded to the study groups.
Anaesthesia was induced and maintained with halothane and 66% nitrous oxide in oxygen. After placement of an intravenous cannula, vecuronium 100 µg/kg was given to facilitate tracheal intubation. The study drug was administered intravenously immediately after tracheal intubation. Pethidine 0.75 mg/kg was used for intraoperative analgesia.
During surgery, lactated Ringer's solution was administered for intraoperative fluid replacement as per recommendations 15 . After intubation, the gastric contents were aspirated with a nasogastric tube and again just prior to extubation. Residual neuromuscular blockade was antagonized with 50 µg/kg neostigmine and 10 µg/kg glycopyrrolate and the trachea extubated when the child was awake.
Postoperatively, the children were observed in the post anaesthesia care unit (PACU) and the time to achieve complete recovery (modified Aldrete score of 10) was recorded. Rescue analgesia was given either when children complained of pain or when younger children cried or rubbed their eyes and were not pacified by feeding or comforting. Supplementary analgesia was provided with intravenous pethidine 0.5 mg/kg until the children tolerated liquids and oral ibuprofen 10 mg/kg thereafter.
Postoperative nausea and vomiting was recorded continuously by a nurse blinded to the intervention and then collated to the three epochs of 0-2 hours, 2-6 hours and 6-24 hours after surgery. Nausea was defined as an unpleasant sensation associated with the awareness of the urge to vomit. Nausea was recorded only in children six years or older. The severity of this subjective sensation was assessed by the visual analogue scale. Vomiting was defined as the forceful expulsion of gastric contents from the mouth or retching. If events of vomiting or retching were separated by more than one minute, they were considered as separate episodes. PONV was graded on a four-point scale: 0=no nausea or vomiting, 1=nausea but no vomiting, 2=one episode of vomiting in 30 minutes, 3=two or more than two episodes of vomiting in 30 minutes. Children with a PONV score of 3 received rescue anti-emetic, metoclopramide 150 µg/kg intravenously. PONV in the first six hours was categorized as early PONV and beyond this was labelled as late PONV.
Adverse effects such as headache and weakness were recorded as they occurred. Parents or guardians of the children were interviewed 24 hours after surgery to assess their level of satisfaction with their child's comfort and PONV status. Satisfaction was graded on an eleven-point (0-10) verbal numerical scale, 0 representing "not at all satisfied" and 10 representing "full satisfaction" 6 . During the postoperative visit at one week, the attending ophthalmologist (blinded to the intervention groups) evaluated the operated eye for evidence of wound infection and delayed healing.
Statistical analysis
One-way analysis of variance was performed to examine the differences in means of quantative variables among the five groups. Categorical variables were analysed using 5x2 Chi square test to determine differences among the five groups, followed by 4x2 Chi square tests for differences among the four dexamethasone groups. A P value of <0.05 was considered statistically significant. The number needed to prevent (NNTP) was calculated as the reciprocal of absolute risk reduction to find the number of children who would need to be treated in order to prevent one case of nausea or vomiting. The analysis was conducted using the statistical package SAS system 8e (Copyright SAS Institute Inc. Cary, NC, U.S.A.)
RESULTS
The groups were comparable with respect to demographic parameters, age, weight, gender distribution, ASA physical status, duration of anaesthesia, duration of surgery and recovery time (Table 1) . "Complete response" was defined as the absence of nausea and vomiting for 24 hours 3,7 ( Figure 1 ). Complete response was noted in 57.1% children who received dexamethasone 50 µg/kg whereas it was observed in only 7.1% of children in the placebo group (P<0.001). There was no statistically significant difference between the four dexamethasone doses. Although Figure 1 
The PONV score was processed to calculate the incidence of nausea and vomiting. The score of 1 was used to compute the incidence of nausea and the scores of 2 and 3 were combined to arrive at the incidence of vomiting. The children who received dexamethasone had a significantly lower incidence of early vomiting compared with those who received placebo. Late vomiting in these children was comparable with and without dexamethasone ( Table 2) . There was no statistically significant difference in efficacy among the four doses of dexamethasone. Dexamethasone 50 µg/kg was as effective as the higher doses in decreasing the incidence of vomiting. Subgroup analysis of the incidence of vomiting between the two age groups showed no statistically significant difference. Nausea, recorded only in the older children (6 years or older), had a lower incidence in the early period with dexamethasone (Table 3 ).
Severity of nausea was similar in the four dexamethasone groups, the mean VAS score ranging from 2.6 to 4.7, whereas the placebo group recorded a mean of 7.1 which was statistically significantly different (P<0.001). The need for rescue medication was low in all groups (Table 4 ). There was no significant difference in the incidence of need for rescue medication between the placebo group (4 of 42) versus the combined dexamethasone groups (8 of 168) (P=0.26). The number needed to prevent (NNTP) nausea and vomiting with various dosages of dexamethasone was low, ranging from 1.9 to 2.6, suggesting that all doses of dexamethasone were efficacious to a clinically relevant degree ( Table 4 ). The mean parent satisfaction score ranged from 7.4 to 8.1 in dexamethasone groups compared with the mean of 6.4 in the placebo group (P<0.001).
None of the children reported headache or dizziness. There was no incident of delayed wound healing or wound infection in any of the children.
DISCUSSION
The high incidence of PONV following strabismus surgery in children has led to an active search for an effective and safe prophylactic pharmacological agent. In recent years, dexamethasone has been emerging as a useful option. The drug has been found to be efficacious 5, 6 , safe 12 and cost-effective 6 when compared with conventional anti-emetics such as metoclopramide or ondansetron. In the absence of dose response studies, dexamethasone has been tried in fixed empiric doses in adult patients. This approach may not be practicable for children.
Since the incidence of PONV varies with many factors, a major strength of this study has been the elimination of most of the confounding factors by selecting only children scheduled for strabismus repair. Likewise other potential confounding factors such as nature of anaesthesia, nature of drugs used, duration of surgery and postoperative pain have been controlled by stringent study design and pre-defined intervention protocols for the same. Therefore, the differences in incidence of PONV observed in this study are due to the effect of dexamethasone. Further age-stratified analysis was done to look for a possible difference in incidence between younger and older children 16 . The efficacy of low doses of dexamethasone make this treatment an attractive option, not only because of decreased risk of side-effects, but also because of the reduction in cost. An earlier study had shown that dexamethasone 150 µg/kg was effective in reducing the incidence of postoperatve vomiting from 72% (placebo) to 40% in children following tonsillectomy 5 . This study demonstrates the efficacy and safety of dexamethasone dosage as low as 50 µg/kg for prophylaxis of PONV in children, with no significant advantage in doses as much as five times higher. It is worth noting that 50 µg/kg may not be the lowest efficacious dosage. Determination of the minimum effective dose will require further studies with lower doses.
The high baseline incidence of PONV in our study reflects not only the high incidence of emesis during strabismus repair, but also good quality data collection. A similar high incidence in the range of 75% to 85% has been observed by other investigators 6, 14 who found a steep decline in incidence of PONV with prophylactic antiemetics including dexamethasone 6 . It might be suggested that our observations indicate that the duration of efficacy of dexamethasone is limited, since the incidence of nausea and vomiting in older children with any dosage of dexamethasone is comparable with placebo during the 6-24 hours epoch. There was no significant increase in the inci- dence of nausea or vomiting in any dexamethasone group with the passage of time. There is a significant decline in nausea and vomiting in the saline group from the 2-6 hour epoch to the 6-24 hour epoch. This is in accord with an earlier study where the incidence of PONV at 24 hours was less than half that at six hours 6 . These observations suggest that there is a natural decline in the incidence of PONV with time, although conflicting data has been reported 17 . In our study, once rescue medication is administered, the absence of nausea or vomiting may be attributable to the "rescue" rather than the prophylactic drug used. This confounds later observations in the study. The low incidence of requirement for rescue medication (4 of 42 in the placebo group, and 8 of 168 in the dexamethasone treated groups) makes it likely that this effect was minimal.
A previous study using dexamethasone 1 mg/kg in children undergoing strabismus surgery reported an anti-emetic effect lasting for 24 hours 6 . Although the reason for this effect is not clear, it has been attributed to the long half-life of the drug 12 , which varies between 36 and 72 hours. High doses are likely to maintain therapeutic effect for 24 hours. This was not observed in our study, probably because of the lower doses used. Similarly, shorter duration of effect has been previously observed with lower doses of dexamethasone 12 .
CONCLUSION This study suggests that doses of dexamethasone as low as 50 µg/kg are effective for prophylaxis of PONV following strabismus repair in children. Higher dosage offers no additional benefit. The minimum effective dose could not be determined in this study.
